Salute e Benessere

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – May 19 , 2023 – 7 .00 PM CETOxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical...

EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the…

Company Announcement Results from phase 2 clinical trial demonstrated EPKINLY™ (epcoritamab-bysp) delivered 61 percent overall response rate , 38 percent complete response, and 15.6-month median duration of response in challenging-to-treatR/R DLBCL patientsEPKINLY represents the seventh approved medicine incorporating Genmab innovation and third created via Genmab's DuoBody ® technology platform COPENHAGEN , Denmark; May ...

USD 306.2 Billion Growth in Active Pharmaceutical Ingredients Market Size -…

Active Pharmaceutical Ingredients Market: Overview Active Pharmaceutical Ingredients Market: Overview The market, also known as the API market, refers to the activities surrounding the production and sales of chemical compounds that are used in the process of pharmaceutical drug production. The ingredients are medication components used to produce desired therapeutic results and are biologically active. The industry is one of the crucial segments of the larger pharmaceutical sector as...

Groupe Casino : Composition of the Board of Administration

Composition of the Board of Administration Paris, May 19, 2023In order not to avoid any risk of conflict of interest within the framework of the study by the Casino group of the proposal of EP Global Commerce a.s. and not to interfere in any way with the work of the Board of Administration, Fimalac has informed Casino, Guichard-Perrachon of his decision to resign from his position as administrator, with immediate effect. ANALYSTS AND INVESTORS CONTACTS Christopher WELTON– Phone...

Longstanding investment fair echoes eastern Chinese province Zhejiang's…

The event's active registration, rich activities and robust exchanges have witnessed the enthusiasm and expectation of global investors for Zhejiang, an open highland in China. The event's active registration, rich activities and robust exchanges have witnessed the enthusiasm and expectation of global investors forZhejiang, an open highland inChina. From an investment & trade event to high-level opening-up platform The ZJITS has witnessed the magnificent course of the province's...

The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code

Shanghai Berry Electronic Tech Co., Ltd. ("Berry Electronic"), a high-tech enterprise focusing on the health and medical field for 20 years, brought its innovative new product Patient Monitor to the Fair for the first time, showing latest R&D achievements of China's health and medical industry to global business people. The Patient Monitor is a small, portable, and multifunctional device that can accurately measure blood oxygen, pulse rate, heartbeat, blood pressure, respiratory…

Canon Launches First Carbon Neutral, Technical Wide Format Papers for the AECM…

Slightly heavier at 80gsm, Recycled White Zero FSC® comes in a range of widths from 297mm to 914mm in 150m rolls and is made from 100% recycled, post-consumer recycled paper, making it the ideal choice for any sustainably conscious organisation. Both papers are compatible with Canon ColorWave, PlotWave and imagePROGRAF series, as well as with other printer brands in the market, providing a versatile option for the AECM industries. Slightly heavier at 80gsm, Recycled White Zero FSC® comes in...

RZNOMICS Inc. received FDA approval to initiate clinical development of…

More specifically, RZ-001 engenders effective anti-GBM activity by suppressing hTERT expression selectively in cancer cells, which over-express hTERT, and simultaneously inducing a cytotoxic effect by trans ligating an HSVtk-encoding sequence into the reprogrammed hTERT mRNA. Moreover, the result of such editing efficiently induces immune cell infiltrations into GBM tumors and hampers angiogenesis in the tumor tissues in preclinical animal models. (http://www.rznomics.com/pipeline/RZ-001.php)…

BBS-Bioactive Bone Substitutes Oyj: The subscription period for the second…

BBS-Bioactive Bone Substitutes Oyj, Company release, 19 May 2023 at 12.00 p.m. EESTBBS-Bioactive Bone Substitutes Oyj: The subscription period for the second warrant series starts on 22 May 2023 – the subscription price is EUR 0.65 per share BBS-Bioactive Bone Substitutes Oyj (BBS) organized a rights issue from May 18 to June 3, 2022. In connection with the share issue, a total of 670,962 warrants from two different series (TO1 and TO2) were also granted to the subscribers. Each warrant...

Alvotech Reports Financial Results for First three Months of 2023 and Provides…

Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period in 2022Confirmatory patient study for AVT05, a proposed biosimilar for Simponi ®and Simponi Aria ®(golimumab) initiated, marking the fifth internally developed portfolio candidate to be dosed in a patient studySatisfactory outcome of facility reinspection remains the key requirement for U.S. approval of Biologics License Applications (BLAs) for AVT02, a...

Study Shows PulseAI's Deep Learning Algorithm Outperforms the Apple Watch ECG…

"We are thrilled to announce that our AI algorithm has proven to be far more accurate in detecting atrial fibrillation than even the latest Apple Watch ECG algorithm," said PulseAI CEO and Founder Alan Kennedy. "Smartwatches with built-in ECG sensors have become increasingly popular, but accurate interpretation of the data from these devices remains a significant challenge. Our breakthrough AI-ECG technology promises to provide numerous benefits for both patients and physicians by…

Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®)…

On the basis of these results and in accordance with the predetermined hypothesis of the interim analysis, Genome & Company highly expect that the evidence for treatment with GEN-001 plus avelumab as a 3rd line of therapy for GC/GEJ will be strongly established. On the basis of these results and in accordance with the predetermined hypothesis of the interim analysis, Genome & Company highly expect that the evidence for treatment with GEN-001 plus avelumab as a 3rd line of therapy for…

Major shareholder announcement

Company announcement No. 10/2023 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, May 19 , 2023 –Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Scandinavian Investment Group A/S, that as of May 16, 2023, Scandinavian Investment Group A/S holds shares corresponding to 10...

The Seventy-sixth World Health Assembly: Urgent global action to prioritise…

There is no better place to make this message heard and to agree solutions than at the World Health Assembly. There is no better place to make this message heard and to agree solutions than at the World Health Assembly. UN Member States acknowledge the impact of COVID-19, conflict, economic and environmental crises on people's mental health. The unprecedented pressure exerted by these emergencies has underscored the urgent need to prioritise mental well-being. All Member States are committed...

EMA validates marketing authorisation application for efanesoctocog alfa for…

Haemophilia A is a rare, genetic disorder in which the ability of a person's blood to clot is impaired due to a lack of factor VIII. Haemophilia A occurs in about one in 5,000 male births annually, and more rarely in females. People with haemophilia can experience bleeding episodes including life-threatening haemorrhages, acute and chronic pain, irreversible joint damage with disability and negative impacts on quality of life. Despite advancements in treatment made in recent years, a large unmet…

EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control…

A new technology: renal nerve mapping+selective denervation A new technology: renal nerve mapping+selective denervation In the SMART study, patients in the msRDN arm have eight mapped sites on unilateral renal artery on average, nearly 50% of which are "hot spots" requiring ablation (4 sites on each artery) and 39.4% of the hot spots require a second ablation (1.5 sites on each artery). Post-ablation feedback mapping ensures effective renal sympathetic denervation by indicating…

HuidaGene Therapeutics Announces Publication of the World's First Guanine…

"Following our publication in Nature Biotechnology early this year of the independently-developed, programmable A-to-Y DNA base editor, AYBE (adenine transversion base editor), we're thrilled that the National Science Review published our paper sharing the comprehensive data on our discovery of the world first guanine-based base editor, gGBE," said Xuan Yao, Ph.D., Co-Founder and Chief Executive Officer of HuidaGene. "CRISPR-Cas9-based CBEs and ABEs can efficiently mediate C-to-T…

Pharmaceutical Manufacturing Equipment Market worth $19.7 billion by 2028 -…

Browse in-depth TOC on "Pharmaceutical Manufacturing Equipment Market" 191 – Tables49 – Figures224 – Pages Browse in-depth TOC on "Pharmaceutical Manufacturing Equipment Market" 191 – Tables 49 – Figures 224 – Pages Silicon Photonics Market Report Scope: Packaging machines are expected to register the highest growth and also hold the largest share of the market followed by mixing and blending machines and spray drying equipment. Packaging machines offer a variety of...

Global Gene Editing Technologies Market to Reach $16.37 Billion by 2032 -…

According to this study, the global gene editing technologies market was valued at $1.81 million in 2022 and is projected to reach $16.37 billion by 2032, growing at a CAGR of 27.50%. According to this study, the global gene editing technologies market was valued at$1.81 millionin 2022 and is projected to reach$16.37 billionby 2032, growing at a CAGR of 27.50%. The following factors are responsible for the increase in demand for gene editing technologies: The detailed study is a...

Glaucoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously…

Key Takeaways from the Glaucoma Competitive Landscape Report Key Takeaways from the Glaucoma Competitive Landscape Report Request a sample and discover the recent advances in glaucoma treatment drugs @Glaucoma Competitive Landscape Report Glaucoma Overview Glaucoma refers to a group of disorders characterized by distinctive cupping of the optic disc and associated visual field abnormalities caused by retinal ganglion cell death. It is a progressive disorder that is the...

At a CAGR of 6.19% ,Global Joint Reconstruction Market to Grow Exponentially by…

Key Takeaways Key Takeaways Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/2601 Elaborating the key trends and dynamics of the Joint Reconstruction Market The surge in the geriatric population base, growing incidences on joint based injuries, and technological evolution in the medical science sector are primarily augmenting the outlook of this business sphere. Moreover, the growing pervasiveness of orthopedic ailments, rising R&D activities...

Ulcerative Colitis Treatment Market to Grow Exponentially by 2029- Brandessence…

Key Takeaways Key Takeaways The Global Ulcerative Colitis Treatment Market is valued atUSD 6958.9 Millionin 2022 and is expected to reachUSD 10394.7 Millionby 2028, amplifying with a CAGR of 5.9% over the forecast period. Get Sample of Report@ https://brandessenceresearch.com/downloadSample/PostId/2600 Elaborating the key trends and dynamics of the Ulcerative Colitis Treatment Market Growing prevalence of gastrointestinal disorders, unhealthy dietary trends of the...

Patient Handling Equipment Market Will Reach USD 18,861.8 Million by 2030, Says…

Another key reason for the rising demand for advanced patient handling equipment is the OSHA guidelines, which aim to protect caregivers from injuries while shifting patients from one room to another. Another key reason for the rising demand for advanced patient handling equipment is the OSHA guidelines, which aim to protect caregivers from injuries while shifting patients from one room to another. Get the sample pages of this report:...

Sports Medicine Market Zooms Towards Billion-Dollar Valuation: Estimated to…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=3753 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=3753 Browse in-depth TOCon" Sports Medicine Market " 202 - Pages 126 – Tables 37 – Figures Sports Medicine Market to Witness Substantial Growth Driven by Increasing Sports Participation and Rising Demand for Injury Management The global sports medicine market is poised for significant expansion in...

Altri Comunicati